Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort-Reference-Cited by-同舟云学术

Is Swollen to Tender Joint Count Ratio a New and Useful Clinical Marker for Biologic Drug Response in Rheumatoid Arthritis? Results From a Swedish Cohort

Published:2014-01-28 Issue:2 Volume:66 Page:173-179
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Kristensen Lars Erik¹²,Bliddal Henning²,Christensen Robin²,Karlsson Johan A.¹,Gülfe Anders¹,Saxne Tore¹,Geborek Pierre¹

Affiliation:

1. Lund University and Skåne University Hospital; Lund Sweden

2. The Parker Institute and Copenhagen University Hospital; Frederiksberg Denmark

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22107/fullpdf

Reference27 articles.

1. Infliximab (chimeric anti-tumor necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial;Maini;Lancet,1999

2. Infliximab and methotrexate in the treatment of rheumatoid arthritis;Lipsky;N Engl J Med,2000

3. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein;Moreland;N Engl J Med,1997

4. Etanercept therapy in rheumatoid arthritis: a randomized controlled trial;Moreland;Ann Intern Med,1999

5. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis;Bathon;N Engl J Med,2000

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to Distinguish Non-Inflammatory from Inflammatory Pain in RA?;Current Rheumatology Reports;2024-08-09

2. Towards Personalized Medicine in Rheumatoid Arthritis;Open Access Rheumatology: Research and Reviews;2024-05

3. Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RA;JCR: Journal of Clinical Rheumatology;2024-05-01

4. “Inflammatory or non-inflammatory pain in inflammatory arthritis – How to differentiate it?”;Best Practice & Research Clinical Rheumatology;2024-03

5. Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL Start;Arthritis Research & Therapy;2023-09-29